News & Updates

A novel infant microbiome formula (SIM03) containing unique Bifidobacterium bifidum and Bifidobacterium breve strains improves eczema severity and quality of life (QoL) in preschool children, shows a study by the Chinese University of Hong Kong (CUHK).

Adding desloratadine to an isotretinoin regimen appears to reduce pruritus in acne, leading to a higher patient satisfaction, as shown in a study.

Treatment with upadacitinib, an oral selective Janus kinase inhibitor, led to greater proportions of days spent with improved nighttime itch and sleep disturbance experienced by patients with moderate-to-severe atopic dermatitis (AD), according to an integrated analysis of the phase III Measure Up 1 and 2 studies presented at AAD 2024.

Home-based phototherapy is equally effective as in-office treatment for plaque or guttate psoriasis regardless of skin type, providing a convenient first-line treatment option for patients, according to data from the Light Treatment Effectiveness (LITE) study.

Injections with polidocanol (10XB-101) help dissolve the pocket of excess fat under the chin, with a faster onset of action and fewer side effects relative to synthetic deoxycholic acid compound (ATX-101) injections, according to the results of a phase IIb study.

Use of Chat Generated Pretrained Transformer (ChatGPT), a free artificial intelligence (AI)-based natural language processing tool, to answer dermatologic questions falls short of expectations, according to a study presented at AAD 2024. Responses by doctors are still preferable to ChatGPT-generated answers.